Huntsman Cancer Institute (HCI) at the University of Utah is a cancer research and treatment center. HCI is a National Cancer Institute (NCI)-Designated Comprehensive Cancer Center, which means it meets the highest standards for cancer care and research and receives support for its scientific endeavors. Learn more about our Cancer Center Research Programs. HCI is also a member of the National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of the world’s leading cancer centers. NCCN is dedicated to improving the quality and effectiveness of care provided to patients with cancer.

Mission Statement 

Huntsman Cancer Institute's mission is to understand cancer from its beginnings, to use that knowledge in the creation and improvement of cancer treatments, to relieve the suffering of cancer patients, and to provide education about cancer risk, prevention, and care. 

Hope Through Research

HCI scientists focus on understanding cancer from its beginnings to create safer and more effective treatments. Researchers also investigate how genes function to discover possible methods of preventing, circumventing, or even reversing the genetic changes that cause cancer.

Hope Through Education

HCI offers free information about cancers, risk factors, screening, prevention, and treatments to patients, family members, physicians, and the public.

Hope Through Care

At HCI, teams of doctors and health care professionals work together to provide compassionate, state-of-the-art care.

Our Patient Reach

HCI serves thousands of cancer patients throughout every year and provides academic and clinical training for future physicians and researchers. Most of our patients come from Utah, a state that covers more than 80,000 square miles, of which 96% is rural (<100 people/square mile) and 70% is frontier (<7 people/square mile). Utah is also home to seven Native American tribes or nations.

Although Utah is our primary catchment area, patients are referred from a broad, multistate region of the Mountain West that includes portions of Idaho, Montana, Nevada, and Wyoming—an area rich in special populations that are historically underserved and exhibit poor cancer outcomes compared to the U.S. average.

HCI is committed to equity in research opportunities for all genders and minority groups in our catchment area. We ensure every person receives excellent cancer care and is able to benefit from the latest advances in cancer diagnosis, treatment, and prevention strategies through participation in clinical trials.

Recent News

Awards, Press Releases, In The Media, HCI News

Cognitive Stimulation, Social Interactions & Physical Activity Increase Lifespan in Mice with Colon Cancer

Living in a stimulating environment has a wide range of health benefits in humans and has even been shown to fight cancer in mice, but the underlying mechanisms have been unclear. A study published April 25 in Cell Reports reveals that cognitive stimulation, social interactions, and physical activity increase lifespan in mice with colon cancer by triggering the body's wound repair response.

Read More

Patient Stories

Advance Care Planning Is a Gift

When Lisa Lindblad’s brain cancer placed her on life support and unable to speak for herself, her family turned to an advance directive Lisa had prepared for that very reason. Watch the video to hear their story.

Read More

Awards, Press Releases, In The Media, HCI News

Huntsman Cancer Institute Investigators Elected to American Academy of Arts and Sciences

University of Utah professors Bradley R. Cairns, professor and chair of Oncological Sciences and senior director of Basic Science at Huntsman Cancer Institute; Dana Carroll, distinguished professor of Biochemistry and HCI investigator; and Christopher D. Hacon, distinguished professor of Mathematics, were raised to a high honor in science today with their election to the American Academy of Arts and Sciences.

Read More

HCI News

Huntsman Cancer Institute Researchers Share Expertise at National Cancer Meeting

More than 20 researchers from Huntsman Cancer Institute (HCI) at the University of Utah made their mark on the American Association of Cancer Research (AACR) Annual Meeting this year. Held in Washington, D.C., the convention drew more than 21,500 cancer researchers from all over the world. Scientists attended sessions on topics from immunotherapy to precision medicine. About 15 researchers from HCI presented posters in the main conference hall, on a wide range of topics.

Read More